Latest News
ASML's Latest Chapter in the Semiconductor Story
We've also got a look at genetic testing company 23andMe .
Author Alok Sama on OpenAI, Bubbles, and When to Sell
We're talking tech.
Most of the U.S. stock market edged lower after the Federal Reserve kicked off its efforts to prevent a recession with a bigger-than-usual cut to interest rates
The lawsuit accused the genetics testing company of failing to protect the privacy of 6.9 million customers whose personal information was exposed in a data breach last year
3 Ultra-High-Yield Dividend Stocks to Buy Hand Over Fist Right This Instant
Business development companies can be a lucrative source of passive income.
Why 23andMe Stock Tumbled 10% on Tuesday
Is altruism a good idea for an unprofitable capitalistic enterprise?
This Technology Company Is Being Acquired at a Shocking 207% Premium -- and These 2 Stocks Could Be Next
Matterport is being acquired by a real estate giant, but it might not be the last ex-SPAC to go this route.
Billionaires Are Snapping Up Beaten-Down 23andMe Stock. Should You Follow Their Lead?
Several well-regarded funds run by famous billionaire investors bought shares of 23andMe during the last three months of 2023.
A Few Years From Now, You'll Probably Wish You'd Followed Billionaire Investors Into This Stock
Nu Holdings went from an idea to a $50 billion business over a handful of years. Several billionaire investors are betting on even more upside.
Is 23andMe Stock a Smart Buy Right Now?
It's having trouble getting its core business model to work.
The 3 Worst Stock Investments I Ever Made -- and What I Learned From Them
Not all of my investments have been winners. Here are three that went badly and the important lessons I learned from them.
INVESTIGATION ALERT: Levi & Korsinsky, LLP Announces Investigation Of 23andMe Holding Co (ME) Data Breach
New York, New York--(Newsfile Corp. - December 7, 2023) - 23andMe, a popular personal genomics and DNA analysis company run by 23andMe Holding Co. ("23 and Me") (NASDAQ: ME), recently suffered a massive data leak. The attack targeted the personal information of 23andMe users -more than 4 million people- compromising...
Why Pancreatic Cancer is No Longer a Death Sentence: Emerging Therapies to Watch
USA News Group – Despite being a relatively rare form of cancer, pancreatic cancer remains one of the deadliest in the oncology field, the third leading cause of cancer death in the USA. Still not fully understood, pancreatic cancer’s...
Better AI Biotech Stock: Recursion Pharmaceuticals vs. 23andMe
Both businesses have a lot to prove.
Why 23andMe Holding Stock Plummeted by 13% Today
Investors reacted sharply and not well to the company's inaugural set of fiscal 2024 earnings.
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating 23andMe Holding Co. for Potential Breaches of Fiduciary Duty By Its Board of Directors
/PRNewswire/ -- Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of...
Better Diversified Biotech Stock: 23andMe vs. Fulgent Genetics
Neither has a traditional business model, but that could be an asset for both.